JPRN-UMIN000005733尚未招募未知
Efficacy of palonosetron for prevention of chemotherapy-induced nausea and vomitting in patients with haematological malignancies - Efficacy of palonosetron for prevention of chemotherapy-induced nausea and vomitting in patients with haematological malignancies
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)hypersensitivity for palonosetron or other 5-HT3 receptor antagonist 2)wiht naisea(CTCAE Grade2) at register 3)judge to be not suitable by the attending physycian
研究者
相似试验
已完成
不适用
Efficacy of palonosetron plus aprepitant in preventing chemoradiotherapy-induced nausea and emesis in patients receiving daily low-dose cisplatin-based concurrent chemoradiotherapy for uterine cervical cancer: a phase II studycervical cancerJPRN-UMIN000011616Chiba University Hospital20
已完成
2 期
Safety and Efficacy of Palonosetron in Preventing Chemotherapy-induced Nausea and VomitingNauseaVomitingChemotherapyNCT00503386Hangzhou Jiuyuan Gene Engineering Co. Ltd.,144
已完成
2 期
The Efficacy and Safety of Palonosetron in Preventing the Gastrointestinal Reactions Induced by 3-day Highly Emetogenic ChemotherapyCancerNCT01909856Jiangsu Simcere Pharmaceutical Co., Ltd.92
已完成
不适用
The effect of Palonosetron for the prevention of postoperative nausea and vomitingKCT0000581Soon Chun Hyang University Hospital Seoul214
已完成
2 期
The study of efficacy and safety of palonosetron for high-risk chemotherapy induced nausea and vomiting in malignant lymphoma.Malignant lymphomaJPRN-UMIN000008966Shimane University Hospital,cancer center54